Toggle Nav
My Cart
English
Español
Menu
Account
  • Log in / Register
    • Language
    English
    Español

    Cipla (Spanish version)

    Deshpande, Rohit ; Winig, Laura

    • Reference: HBS-520S15

    • Year: 2003

    • Number of pages: 22

    • Geographic Setting: India

    • Publication Date: Jun 23, 2003

    • Fecha de edición: May 10, 2006

    • Source: HBSP (USA)

    • Type of Document: Case

    • Industry Setting: Pharmaceuticals

    Grouped product items
    Format Language Reference Use Qty Price
    pdf Spanish HBS-520S15
    As low as €8.20

    You already have a subscription
    To order please contact the person in charge of academic purchases in your university.
    You'll be able to order once your profile has been validated.

    Description

    The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line could become unsaleable (given that it is based on product patents protected in industrialized countries). Describes Cipla's role in forcing global pharmaceutical companies to lower their prices for AIDS drugs.

    Keywords

    AIDS Business ethics corporate social responsibility Patents Pricing Pricing strategy Product lines Social issues Social responsibility